IFF Q2 sales rise 2% to $1.95B; EPS $0.13 vs $2.14 a year earlier
IFF reported second-quarter 2026 results on a continuing operations basis, with net sales of $1.95 billion, up 2% from a year earlier, and adjusted operating EBITDA of $408 million. Reported diluted EPS was $0.13, down from $2.14 in the prior-year period, which included a $488 million gain on debt extinguishment. IFF also set full-year 2026 guidance for continuing operations and announced a $2.5 billion share repurchase authorization alongside the planned sale of its Food Ingredients business to CVC Capital Partners for about $3.8 billion in net cash proceeds.
Key points
- Q2 comparable currency neutral sales rose 6%, and comparable currency neutral adjusted operating EBITDA rose 6%, per the filing.
- Full-year 2026 continuing operations guidance: sales of $7.4 billion to $7.6 billion and adjusted operating EBITDA of $1.53 billion to $1.60 billion.
- Food Ingredients sale to CVC Capital Partners is expected to close by the end of the second quarter of 2027; IFF plans to use proceeds to reduce debt by over $1 billion.
- Repurchase authorization of $2.5 billion includes a $500 million accelerated share repurchase planned for the second half of 2026.
The filing
Written by AI on Nov 8, 2026, 12:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 04, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.